(Q35922763)

11 August 2017

1 reference

title

Drug treatment of pneumococcal pneumonia in the elderly (English)

1 reference

11 August 2017

1 reference

pneumococcal pneumonia

1 reference

Sridhar Neralla

1

1 reference

11 August 2017

Keith C Meyer

series ordinal

2

1 reference

11 August 2017

publication date

1 January 2004

1 reference

11 August 2017

1 reference

11 August 2017

volume

21

1 reference

11 August 2017

issue

13

1 reference

11 August 2017

page(s)

851-864

1 reference

Pathogenesis of Pneumococcal Infection

11 August 2017

cites work

1 reference

12 December 2020

Effect of Macrolides as Part of Initial Empiric Therapy on Length of Stay in Patients Hospitalized With Community-Acquired Pneumonia

1 reference

12 December 2020

An international prospective study of pneumococcal bacteremia: correlation with in vitro resistance, antibiotics administered, and clinical outcome

1 reference

12 December 2020

Prevalence of antimicrobial resistance among respiratory tract isolates of Streptococcus pneumoniae in North America: 1997 results from the SENTRY antimicrobial surveillance program

1 reference

12 December 2020

Antibacterial resistance in Streptococcus pneumoniae and Haemophilus influenzae from Italy and Spain: data from the PROTEKT surveillance study, 1999-2000.

1 reference

12 December 2020

Membrane damage by pore-forming bacterial cytolysins

1 reference

12 December 2020

Identification of pneumococcal surface protein A as a lactoferrin-binding protein of Streptococcus pneumoniae

1 reference

12 December 2020

Role of Pneumolysin's complement-activating activity during pneumococcal bacteremia in cirrhotic rats.

1 reference

12 December 2020

The role of immunity in susceptibility to respiratory infection in the aging lung

1 reference

12 December 2020

Linezolid vs vancomycin: analysis of two double-blind studies of patients with methicillin-resistant Staphylococcus aureus nosocomial pneumonia

1 reference

12 December 2020

Activity of linezolid against multi-resistant gram-positive bacteria from diverse hospitals in the United Kingdom.

1 reference

12 December 2020

Association of intrastrain phase variation in quantity of capsular polysaccharide and teichoic acid with the virulence of Streptococcus pneumoniae

1 reference

12 December 2020

Comparison of pneumococcal polysaccharide and CRM197-conjugated pneumococcal oligosaccharide vaccines in young and elderly adults.

1 reference

12 December 2020

Addition of a macrolide to a beta-lactam-based empirical antibiotic regimen is associated with lower in-hospital mortality for patients with bacteremic pneumococcal pneumonia

1 reference

12 December 2020

Phosphorylcholine on the lipopolysaccharide of Haemophilus influenzae contributes to persistence in the respiratory tract and sensitivity to serum killing mediated by C-reactive protein

1 reference

12 December 2020

Pneumolysin, a protein toxin of Streptococcus pneumoniae, induces nitric oxide production from macrophages

1 reference

12 December 2020

Emergence of levofloxacin-resistant pneumococci in immunocompromised adults after therapy for community-acquired pneumonia

1 reference

12 December 2020

Cytokine kinetics and other host factors in response to pneumococcal pulmonary infection in mice

1 reference

12 December 2020

Pneumococcal macrolide resistance--myth or reality?

1 reference

12 December 2020

A study of pathogenic factors of Streptococcus pneumoniae strains causing meningitis

1 reference

12 December 2020

Pneumococcal vaccine: clinical efficacy and effectiveness

1 reference

12 December 2020

Pneumonia acquired in the community through drug-resistant Streptococcus pneumoniae

1 reference

12 December 2020

Pharmacodynamic comparisons of levofloxacin, ciprofloxacin, and ampicillin against Streptococcus pneumoniae in an in vitro model of infection

1 reference

12 December 2020

Management of community-acquired pneumonia in the era of pneumococcal resistance: a report from the Drug-Resistant Streptococcus pneumoniae Therapeutic Working Group

1 reference

12 December 2020

Comparative activity of gatifloxacin and other antibiotics against 4009 clinical isolates of Streptococcus pneumoniae in the United States during 1999-2000.

1 reference

12 December 2020

Reactogenicity and immunogenicity of a protein-conjugated pneumococcal oligosaccharide vaccine in older adults

1 reference

12 December 2020

Risk factors for acquisition of levofloxacin-resistant Streptococcus pneumoniae: a case-control study

1 reference

12 December 2020

Attacking the pneumococcus -- a hundred years' war.

1 reference

12 December 2020

Effectiveness of pneumococcal polysaccharide vaccine in older adults

1 reference

12 December 2020

Community-acquired pneumonia in the elderly: A multivariate analysis of risk and prognostic factors

1 reference

12 December 2020

Clinical efficacy of pneumococcal vaccine in the elderly: a randomized, single-blind population-based trial

1 reference

12 December 2020

Pneumococcal bacteremia in two tertiary care hospitals in Winnipeg, Canada. Pneumococcal Bacteremia Study Group

1 reference

12 December 2020

Pneumonia in the elderly

1 reference

12 December 2020

Adult bacteremic pneumococcal pneumonia in a community teaching hospital, 1992-1996. A detailed analysis of 108 cases

1 reference

12 December 2020

High incidence of silent aspiration in elderly patients with community-acquired pneumonia

1 reference

12 December 2020

Activity of linezolid against levofloxacin-resistant Streptococcus pneumoniae, methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci in Hong Kong

1 reference

12 December 2020

Resistance to levofloxacin and failure of treatment of pneumococcal pneumonia

1 reference

12 December 2020

Macrolide resistance among invasive Streptococcus pneumoniae isolates

1 reference

12 December 2020

Impact of penicillin susceptibility on medical outcomes for adult patients with bacteremic pneumococcal pneumonia

1 reference

12 December 2020

Influenza and pneumococcal vaccination levels among persons aged > or = 65 years--United States, 2001

1 reference

12 December 2020

Neutrophil survival is markedly reduced by incubation with influenza virus and Streptococcus pneumoniae: role of respiratory burst

1 reference

12 December 2020

Immunization of humans with recombinant pneumococcal surface protein A (rPspA) elicits antibodies that passively protect mice from fatal infection with Streptococcus pneumoniae bearing heterologous PspA

1 reference

12 December 2020

Influence of Age on Symptoms at Presentation in Patients With Community-Acquired Pneumonia

1 reference

12 December 2020

Geographic, demographic, and seasonal differences in penicillin-resistant Streptococcus pneumoniae in Baltimore

1 reference

12 December 2020

Failure of Macrolide Antibiotic Treatment in Patients with Bacteremia Due to Erythromycin‐Resistant Streptococcus pneumoniae

1 reference

12 December 2020

PspA and PspC: their potential for use as pneumococcal vaccines

1 reference

12 December 2020

Etiology of community-acquired pneumonia: impact of age, comorbidity, and severity

1 reference

12 December 2020

Molecular and cellular biology of pneumococcal infection

1 reference

12 December 2020

Community-acquired pneumonia in the elderly. Clinical and nutritional aspects

1 reference

12 December 2020

Regional trends in antimicrobial resistance among clinical isolates of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States: results from the TRUST Surveillance Program, 1999-2000.

1 reference

12 December 2020

Prevalence of macrolide resistance mechanisms in Streptococcus pneumoniae isolates from a multicenter antibiotic resistance surveillance study conducted in the United States in 1994-1995.

1 reference

12 December 2020

Community-acquired pneumonia in elderly patients

1 reference

12 December 2020

An outbreak of multidrug-resistant pneumococcal pneumonia and bacteremia among unvaccinated nursing home residents.

1 reference

12 December 2020

Age-associated differences in immunoglobulin G1 (IgG1) and IgG2 subclass antibodies to pneumococcal polysaccharides following vaccination.

1 reference

12 December 2020

Spread of drug-resistant Streptococcus pneumoniae in Asian countries: Asian Network for Surveillance of Resistant Pathogens (ANSORP) Study

1 reference

12 December 2020

Analysis of ciprofloxacin activity against Streptococcus pneumoniae after 10 years of use in the United States

1 reference

12 December 2020

Microbiological profile of telithromycin, the first ketolide antimicrobial

1 reference

12 December 2020

Reversal of tetracycline resistance mediated by different bacterial tetracycline resistance determinants by an inhibitor of the Tet(B) antiport protein.

1 reference

12 December 2020

Clinical prognostic indices of fatality in elderly patients admitted to hospital with acute pneumonia

1 reference

12 December 2020

Penicillin dosing for pneumococcal pneumonia

1 reference

12 December 2020

Mortality from invasive pneumococcal pneumonia in the era of antibiotic resistance, 1995-1997

1 reference

12 December 2020

Intrapulmonary pharmacokinetics of linezolid

1 reference

12 December 2020

Ketolides: a new class of antibacterial agents for treatment of community-acquired respiratory tract infections in a primary care setting

1 reference

12 December 2020

Pathogenesis of pneumococcal infection

1 reference

12 December 2020

Pneumococcal vaccination: current and future issues

1 reference

12 December 2020

The cost of treating community-acquired pneumonia.

1 reference

12 December 2020

Lung infections and aging

1 reference

12 December 2020

Adenovirus infection enhances in vitro adherence of Streptococcus pneumoniae

1 reference

12 December 2020

Pneumococcal virulence factors: structure and function

1 reference

12 December 2020

Pneumococcal Vaccination and Revaccination of Older Adults

1 reference

12 December 2020

In vitro activity of the new ketolide telithromycin and other antibiotics against Streptococcus pneumoniae in Belgium

1 reference

12 December 2020

Effects of amino acid alterations in penicillin-binding proteins (PBPs) 1a, 2b, and 2x on PBP affinities of penicillin, ampicillin, amoxicillin, cefditoren, cefuroxime, cefprozil, and cefaclor in 18 clinical isolates of penicillin-susceptible, -inte

1 reference

12 December 2020

Pneumonia in the elderly. Special diagnostic and therapeutic considerations

1 reference

12 December 2020

High-level fluoroquinolone resistance in Streptococcus pneumoniae requires mutations in parC and gyrA.

1 reference

12 December 2020

Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention

1 reference

12 December 2020

Is Streptococcus pneumoniae the leading cause of pneumonia of unknown etiology? A microbiologic study of lung aspirates in consecutive patients with community-acquired pneumonia

1 reference

12 December 2020

The nature of cell wall-derived inflammatory components of pneumococci

1 reference

12 December 2020

Resistance among Streptococcus pneumoniae: Implications for drug selection

1 reference

12 December 2020

Defining prognostic factors in the elderly with community acquired pneumonia: a case controlled study of patients aged > or = 75 yrs.

1 reference

12 December 2020

Penicillin resistance and other predictors of mortality in pneumococcal bacteremia in a population with high human immunodeficiency virus seroprevalence

1 reference

12 December 2020

10.2165/00002512-200421130-00003

Identifiers

DOI

1 reference

Dimensions Publication ID

11 August 2017

1018423903

0 references

1 reference